Risk prediction of 30-day mortality after stroke using machine learning: a nationwide registry-based cohort study.

30-day mortality Machine learning Outcomes Quality improvement Risk prediction Statistical analysis Stroke

Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
27 May 2022
Historique:
received: 15 11 2021
accepted: 17 05 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

We aimed to develop and validate machine learning (ML) models for 30-day stroke mortality for mortality risk stratification and as benchmarking models for quality improvement in stroke care. Data from the UK Sentinel Stroke National Audit Program between 2013 to 2019 were used. Models were developed using XGBoost, Logistic Regression (LR), LR with elastic net with/without interaction terms using 80% randomly selected admissions from 2013 to 2018, validated on the 20% remaining admissions, and temporally validated on 2019 admissions. The models were developed with 30 variables. A reference model was developed using LR and 4 variables. Performances of all models was evaluated in terms of discrimination, calibration, reclassification, Brier scores and Decision-curves. In total, 488,497 stroke patients with a 12.3% 30-day mortality rate were included in the analysis. In 2019 temporal validation set, XGBoost model obtained the lowest Brier score (0.069 (95% CI: 0.068-0.071)) and the highest area under the ROC curve (AUC) (0.895 (95% CI: 0.891-0.900)) which outperformed LR reference model by 0.04 AUC (p < 0.001) and LR with elastic net and interaction term model by 0.003 AUC (p < 0.001). All models were perfectly calibrated for low (< 5%) and moderate risk groups (5-15%) and ≈1% underestimation for high-risk groups (> 15%). The XGBoost model reclassified 1648 (8.1%) low-risk cases by the LR reference model as being moderate or high-risk and gained the most net benefit in decision curve analysis. All models with 30 variables are potentially useful as benchmarking models in stroke-care quality improvement with ML slightly outperforming others.

Sections du résumé

BACKGROUNDS BACKGROUND
We aimed to develop and validate machine learning (ML) models for 30-day stroke mortality for mortality risk stratification and as benchmarking models for quality improvement in stroke care.
METHODS METHODS
Data from the UK Sentinel Stroke National Audit Program between 2013 to 2019 were used. Models were developed using XGBoost, Logistic Regression (LR), LR with elastic net with/without interaction terms using 80% randomly selected admissions from 2013 to 2018, validated on the 20% remaining admissions, and temporally validated on 2019 admissions. The models were developed with 30 variables. A reference model was developed using LR and 4 variables. Performances of all models was evaluated in terms of discrimination, calibration, reclassification, Brier scores and Decision-curves.
RESULTS RESULTS
In total, 488,497 stroke patients with a 12.3% 30-day mortality rate were included in the analysis. In 2019 temporal validation set, XGBoost model obtained the lowest Brier score (0.069 (95% CI: 0.068-0.071)) and the highest area under the ROC curve (AUC) (0.895 (95% CI: 0.891-0.900)) which outperformed LR reference model by 0.04 AUC (p < 0.001) and LR with elastic net and interaction term model by 0.003 AUC (p < 0.001). All models were perfectly calibrated for low (< 5%) and moderate risk groups (5-15%) and ≈1% underestimation for high-risk groups (> 15%). The XGBoost model reclassified 1648 (8.1%) low-risk cases by the LR reference model as being moderate or high-risk and gained the most net benefit in decision curve analysis.
CONCLUSIONS CONCLUSIONS
All models with 30 variables are potentially useful as benchmarking models in stroke-care quality improvement with ML slightly outperforming others.

Identifiants

pubmed: 35624434
doi: 10.1186/s12883-022-02722-1
pii: 10.1186/s12883-022-02722-1
pmc: PMC9137068
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56.
doi: 10.1038/s41591-018-0300-7
Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2(4):230–43.
doi: 10.1136/svn-2017-000101
Shah P, Kendall F, Khozin S, et al. Artificial intelligence and machine learning in clinical development: a translational perspective. NPJ Digit Med. 2019;2:69 Published 2019 Jul 26.
doi: 10.1038/s41746-019-0148-3
Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12–22.
doi: 10.1016/j.jclinepi.2019.02.004
Amisha MP, Pathania M, Rathaur VK. Overview of artificial intelligence in medicine. J Family Med Prim Care. 2019;8(7):2328–31.
doi: 10.4103/jfmpc.jfmpc_440_19
Wang W, Kiik M, Peek N, Curcin V, Marshall IJ, et al. A systematic review of machine learning models for predicting outcomes of stroke with structured data. PLoS One. 2020;15(6):e0234722.
doi: 10.1371/journal.pone.0234722
Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13:1.
doi: 10.1186/s12916-014-0241-z
Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20(1):40–9.
doi: 10.1002/mpr.329
Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Stat Soc. 2005;67:301–20.
doi: 10.1111/j.1467-9868.2005.00503.x
Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD '16). New York: Association for Computing Machinery; 2016. p. 785–94.
doi: 10.1145/2939672.2939785
Bray BD, Campbell J, Cloud GC, Hoffman A, James M, Tyrrell PJ, et al. Intercollegiate stroke working party group. Derivation and external validation of a case mix model for the standardized reporting of 30-day stroke mortality rates. Stroke. 2014;45(11):3374–80.
doi: 10.1161/STROKEAHA.114.006451
Gerds TA, Cai T, Schumacher M. The performance of risk prediction models. Biom J. 2008;50(4):457–79.
doi: 10.1002/bimj.200810443
Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925–31.
doi: 10.1093/eurheartj/ehu207
Singh V, Rana RK, Singhal R. Analysis of repeated measurement data in the clinical trials. J Ayurveda Integr Med. 2013;4(2):77–81.
doi: 10.4103/0975-9476.113870
Hochberg Y. A sharper bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800–2.
doi: 10.1093/biomet/75.4.800
Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Topic group ‘evaluating diagnostic tests and prediction models’ of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.
doi: 10.1186/s12916-019-1466-7
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26(6):565–74.
doi: 10.1177/0272989X06295361
Fahey M, Crayton E, Wolfe C, Douiri A. Clinical prediction models for mortality and functional outcome following ischemic stroke: a systematic review and meta-analysis. PLoS One. 2018;13(1):e0185402.
doi: 10.1371/journal.pone.0185402
Dutta D, Cannon A, Bowen E. Validation and comparison of two stroke prognostic models for in hospital, 30-day and 90-day mortality. Eur Stroke J. 2017;2(4):327–34.
doi: 10.1177/2396987317703581
Yu P, Pan Y, Wang Y, et al. External validation of a case-mix adjustment model for the standardized reporting of 30-day stroke mortality rates in China. PLoS One. 2016;11(11):e0166069 Published 2016 Nov 15.
doi: 10.1371/journal.pone.0166069
O’Donnell MJ, Fang J, D’Uva C, Saposnik G, Gould L, McGrath E, et al. Investigators of the registry of the Canadian stroke network. The PLAN score: a bedside prediction rule for death and severe disability following acute ischemic stroke. Arch Intern Med. 2012;172:1548–56.
doi: 10.1001/2013.jamainternmed.30
Saposnik G, Kapral MK, Liu Y, Hall R, O’Donnell M, Raptis S, et al. Investigators of the registry of the Canadian stroke network; stroke outcomes research Canada (SORCan) working group. IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation. 2011;123:739–49.
doi: 10.1161/CIRCULATIONAHA.110.983353
Matsumoto K, Nohara Y, Soejima H, Yonehara T, Nakashima N, Kamouchi M. Stroke prognostic scores and data-driven prediction of clinical outcomes after acute ischemic stroke. Stroke. 2020;51:1477–83.
doi: 10.1161/STROKEAHA.119.027300
Gattringer T, Posekany A, Niederkorn K, Knoflach M, Poltrum B, Mutzenbach S, et al. Austrian stroke unit registry collaborators. Predicting early mortality of acute ischemic stroke. Stroke. 2019;50(2):349–56.
doi: 10.1161/STROKEAHA.118.022863

Auteurs

Wenjuan Wang (W)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK. wenjuan.wang@kcl.ac.uk.

Anthony G Rudd (AG)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK.

Yanzhong Wang (Y)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK.
NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
NIHR Applied Research Collaboration (ARC) South London, London, UK.

Vasa Curcin (V)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK.
NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
NIHR Applied Research Collaboration (ARC) South London, London, UK.

Charles D Wolfe (CD)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK.
NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
NIHR Applied Research Collaboration (ARC) South London, London, UK.

Niels Peek (N)

Division of Informatics, Imaging and Data Science, School of Health Sciences, University of Manchester, Manchester, UK.
NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Benjamin Bray (B)

School of Population Health & Environmental Sciences, Faculty of Life Science and Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH